Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

8.50 

-0.52 -5.8%

as of Nov 15 '19

52 Week Range:

7.89 14.19


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, the company sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. It manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. The company's private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19
Equity (BVPS) 3.59
4.20
5.06
5.66
5.79
5.88
6.65
7.21
8.64
8.31
10.61
growth rate 17.0% 20.5% 11.9% 2.3% 1.6% 13.1% 8.4% 19.8% -3.8% 27.7%
Earnings BIT -0.13
3.03
2.28
6.30
2.10
4.98
5.76
14.26
13.90
12.43
8.36
growth rate 100.0% -24.8% 176.3% -66.7% 137.0% 15.7% 147.6% -2.5% -10.6% -32.8%
Avg.PE -208.90
11.34
6.89
12.87
20.20
18.18
12.94
8.12
7.61
17.43
9.61
growth rate 100.0% -39.2% 86.8% 57.0% -10.0% -28.8% -37.3% -6.3% 129.0% -44.9%
ROA -9.78
11.37
13.16
9.41
3.35
4.03
6.31
14.92
9.86
6.40
7.32
growth rate 100.0% 15.7% -28.5% -64.4% 20.3% 56.6% 136.5% -33.9% -35.1% 14.4%
ROE -14.56
14.57
15.39
11.04
3.91
4.82
7.75
19.56
12.60
7.81
9.06
growth rate 100.0% 5.6% -28.3% -64.6% 23.3% 60.8% 152.4% -35.6% -38.0% 16.0%
ROIC -13.04
14.80
15.47
11.19
3.87
4.78
7.72
19.41
12.12
6.59
7.20
growth rate 100.0% 4.5% -27.7% -65.4% 23.5% 61.5% 151.4% -37.6% -45.6% 9.3%
Cur. Ratio 2.68
4.96
5.63
5.05
5.94
4.26
4.79
2.91
5.03
4.56
5.01
growth rate 85.1% 13.5% -10.3% 17.6% -28.3% 12.4% -39.3% 72.9% -9.3% 9.9%
Quick Ratio 1.26
3.09
3.77
3.45
3.95
2.77
3.16
1.72
3.56
2.78
2.94
growth rate 145.2% 22.0% -8.5% 14.5% -29.9% 14.1% -45.6% 107.0% -21.9% 5.8%
Leverage 1.40
1.18
1.16
1.18
1.16
1.23
1.23
1.38
1.19
1.25
1.23
growth rate -15.7% -1.7% 1.7% -1.7% 6.0% 0.0% 12.2% -13.8% 5.0% -1.6%
Balance Sheet Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19
Acct.Receivable 5.70
4.60
3.30
8.80
6.80
7.06
10.21
13.23
8.67
16.12
16.87
growth rate -19.3% -28.3% 166.7% -22.7% 3.9% 44.6% 29.6% -34.5% 85.9% 4.6%
Acct.Payable 3.90
3.50
6.42
4.65
12.82
5.12
9.65
8.63
growth rate -10.3% 83.4% -27.6% 175.9% -60.1% 88.6% -10.5%
Cur.Assets 22.10
22.80
27.80
34.50
35.30
40.90
43.60
55.88
51.70
65.18
71.39
growth rate 3.2% 21.9% 24.1% 2.3% 15.9% 6.6% 28.2% -7.5% 26.1% 9.5%
Total Assets 36.40
36.10
41.10
47.20
46.60
52.26
53.82
74.18
72.61
85.21
93.49
growth rate -0.8% 13.9% 14.8% -1.3% 12.1% 3.0% 37.8% -2.1% 17.4% 9.7%
Cash 4.00
8.50
15.50
14.50
16.70
19.51
18.55
19.75
27.84
23.61
25.04
growth rate 112.5% 82.4% -6.5% 15.2% 16.8% -4.9% 6.5% 41.0% -15.2% 6.0%
Inventory 9.30
7.30
6.50
8.40
10.00
12.84
12.56
20.77
13.73
23.57
26.00
growth rate -21.5% -11.0% 29.2% 19.1% 28.4% -2.2% 65.3% -33.9% 71.7% 10.3%
Cur.Liabilities 8.30
4.60
4.90
6.80
5.90
9.60
9.09
19.21
10.27
14.28
14.25
growth rate -44.6% 6.5% 38.8% -13.2% 62.7% -5.3% 111.2% -46.5% 39.1% -0.2%
Liabilities 10.40
5.50
5.70
7.30
6.30
9.82
9.96
20.45
11.46
16.96
17.41
growth rate -47.1% 3.6% 28.1% -13.7% 55.9% 1.4% 105.4% -43.9% 48.0% 2.6%
LT Debt 0.60
0.00
0.00
0.00
0.00
0.00
0.00
0.00
growth rate -100.0%
Equity 26.00
30.60
35.50
39.90
40.30
42.44
43.86
53.73
61.15
68.25
76.08
growth rate 17.7% 16.0% 12.4% 1.0% 5.3% 3.4% 22.5% 13.8% 11.6% 11.5%
Common Shares 7.00
7.00
7.00
7.00
7.00
7.00
7.00
7.00
7.00
7.00
7.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19
Capital Expenditures 0.00
0.00
0.00
2.28
1.62
2.68
1.71
10.44
5.35
4.08
5.33
growth rate -29.0% 65.3% -36.2% 511.3% -48.7% -23.8% 30.5%
Cash Dividends 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
growth rate
Cash From OA 4.90
7.10
9.10
1.70
4.50
5.35
2.68
9.29
14.14
1.83
6.56
growth rate 44.9% 28.2% -81.3% 164.7% 18.8% -49.9% 246.7% 52.3% -87.0% 258.1%
FCF per Share 0.05
0.64
1.04
-0.01
0.62
0.08
0.75
-0.68
1.05
1.03
-0.08
growth rate 1,180.0% 62.5% -100.0% 100.0% -87.1% 837.5% -100.0% 100.0% -1.9% -100.0%
Sale Purchase of Stock -0.40
-0.70
-0.06
-2.02
-0.65
-0.71
growth rate 0.0% 0.0% 0.0% 0.0% 0.0%
FCF 0.40
5.00
7.00
-1.00
3.00
3.00
1.00
-1.00
9.00
-2.00
1.00
growth rate 1,150.0% 40.0% -100.0% 100.0% 0.0% -66.7% -100.0% 100.0% -100.0% 100.0%
Income Statement Jun '09 Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19
Sales 73.90
65.60
55.90
72.80
62.80
73.94
79.51
114.20
121.95
132.44
138.29
growth rate -11.2% -14.8% 30.2% -13.7% 17.7% 7.5% 43.6% 6.8% 8.6% 4.4%
Op.Income 0.40
3.30
2.30
4.20
1.60
4.98
5.76
14.26
13.90
12.43
8.36
growth rate 725.0% -30.3% 82.6% -61.9% 211.1% 15.7% 147.6% -2.5% -10.6% -32.8%
IBT -0.10
3.00
2.40
6.20
2.10
2.67
4.31
13.57
10.11
10.61
7.95
growth rate 100.0% -20.0% 158.3% -66.1% 27.1% 61.4% 215.1% -25.5% 5.0% -25.1%
Net Income -4.10
4.10
5.10
4.20
1.60
1.99
3.35
9.55
7.24
5.05
6.54
growth rate 100.0% 24.4% -17.7% -61.9% 24.6% 67.8% 185.3% -24.2% -30.2% 29.5%
EPS -0.58
0.58
0.71
0.59
0.23
0.29
0.49
1.44
1.09
0.73
0.92
growth rate 100.0% 22.4% -16.9% -61.0% 26.1% 69.0% 193.9% -24.3% -33.0% 26.0%
Gross Profit 9.40
10.90
10.60
18.50
11.80
12.74
14.34
25.26
26.20
26.32
23.58
growth rate 16.0% -2.8% 74.5% -36.2% 8.0% 12.6% 76.2% 3.8% 0.4% -10.4%

Quarterly Statements

Item Name Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Earnings BIT 2.72
2.21
1.84
1.60
-0.06
growth rate -19.0% -16.9% -13.1% -100.0%
Balance Sheet Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Acct.Receivable 14.23
13.54
16.79
16.87
14.83
growth rate -4.9% 24.1% 0.5% -12.1%
Acct.Payable 10.06
9.66
12.37
8.63
9.77
growth rate -4.0% 28.0% -30.2% 13.2%
Cur.Assets 69.91
71.15
76.29
71.39
73.05
growth rate 1.8% 7.2% -6.4% 2.3%
Total Assets 90.10
92.83
98.46
93.49
115.24
growth rate 3.0% 6.1% -5.0% 23.3%
Cash 27.61
30.27
27.66
25.04
28.50
growth rate 9.6% -8.6% -9.5% 13.8%
Inventory 24.97
23.48
27.02
26.00
24.84
growth rate -6.0% 15.1% -3.8% -4.5%
Cur.Liabilities 15.42
14.62
18.21
14.25
14.94
growth rate -5.2% 24.5% -21.8% 4.8%
Liabilities 18.23
17.70
21.43
17.41
37.83
growth rate -2.9% 21.1% -18.8% 117.4%
LT Debt
growth rate
Equity 71.88
75.13
77.03
76.08
77.41
growth rate 4.5% 2.5% -1.2% 1.7%
Common Shares 0.09
0.09
0.09
0.09
0.09
growth rate 0.0% 2.4% 0.0% 0.0%
Cash Flow Statement Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Capital Expenditures 0.80
1.87
1.49
1.18
1.12
growth rate 134.4% -20.3% -20.8% -5.1%
Cash Dividends
growth rate
Cash From OA 4.75
3.44
-0.61
-1.02
4.59
growth rate -27.5% -100.0% 0.0% 100.0%
Sale Purchase of Stock
growth rate
FCF 3.95
1.58
-2.09
-2.19
3.48
growth rate -60.1% -100.0% 0.0% 100.0%
Income Statement Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Sales 36.53
36.04
35.46
30.26
29.20
growth rate -1.3% -1.6% -14.7% -3.5%
Op.Income 2.72
2.21
1.84
1.60
-0.06
growth rate -19.0% -16.9% -13.1% -100.0%
IBT 3.22
2.75
2.46
-0.48
0.12
growth rate -14.6% -10.7% -100.0% 100.0%
Net Income 2.56
2.18
1.99
-0.19
0.10
growth rate -14.8% -8.6% -100.0% 100.0%
EPS
growth rate
Gross Profit 7.16
6.44
6.33
3.65
4.38
growth rate -10.2% -1.7% -42.3% 20.1%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (50.57)

YOY Growth Grade:

D (43.57)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 9.80 9.24 15.39
EPS / Growth 32.3% 0.92

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 11.5%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 11.5% 21.9% 21.9%
Future PE 9.80 13.53 23.01
Future EPS 2.74 6.68 6.68
Value Price
MOS %
6.64
-21.9%
22.32
162.6%
37.97
346.7%
MOS Price 3.32 11.16 18.99
IRT 6.14 4.93 4.93

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.